Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Acta Neurologica Belgica|June 17, 2026
Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosisSanaz Khodadadi, Nasim Rezaeimanesh, Tarlan Varzandi, et al.
Nutrients|August 12, 2023
Higher Dietary Acid Load Might Be a Potent Derivative Factor for Multiple Sclerosis: The Results from a Case-Control StudyZahra Saeedirad, Shadi Ariyanfar, Morvarid Noormohammadi, et al.
Scientific Reports|May 9, 2025
Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trialAmeneh Shokati, Mohsen Nikbakht, Mohammad Ali Sahraian, et al.
Caspian Journal of Internal Medicine|March 11, 2024
Effect of ginseng on fatigue related to neuromyelitis optica spectrum disorder: A double-blinded randomized controlled clinical trialSara Aslzadeh, Shaghayegh Shahmirzaei, Mohammad Ali Sahraian, et al.
Advanced Pharmaceutical Bulletin|February 1, 2020
Effect of Whey Protein Supplementation on Inflammatory and Antioxidant Markers, and Clinical Prognosis in Acute Ischemic Stroke (TNS Trial): A Randomized, Double Blind, Controlled, Clinical TrialMazyar Hashemilar, Mohammad Khalili, Nasim Rezaeimanesh, et al.
BMC Neurology|May 2, 2026
The influence of adolescent diet on the occurrence of late-onset multiple sclerosis: a population-based case-control studyNaghmeh Abbasi Kasbi, Nasim Rezaeimanesh, Sanaz Khodadadi, et al.
Advanced Pharmaceutical Bulletin|May 7, 2020
Effects of Alpha Lipoic Acid Supplementation on Serum Levels of Oxidative Stress, Inflammatory Markers and Clinical Prognosis among Acute Ischemic Stroke Patients: A Randomized, Double Blind, TNS TrialSheyda Shaafi, Soraiya Ebrahimpour-Koujan, Mohammad Khalili, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2025
Comorbidity and cardiovascular risk factors in multiple sclerosisMahdi Barzegar, Sara Samadzadeh, Kosar Kohandel, et al.
Multiple Sclerosis and Related Disorders|December 13, 2021
Characteristics of COVID-19 in patients with multiple sclerosisFereshteh Ghadiri, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 13, 2025
Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trialNaghmeh Abbasi Kasbi, Ali Rezaei, Reyhaneh Montazeri, et al.
Pageof 5